| 000 | 01356 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518032316.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1757-790X | ||
| 024 | 7 |
_a10.1136/bcr-2018-228573 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOsimo, Emanuele F | |
| 245 | 0 | 0 |
_aCan typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia? _h[electronic resource] |
| 260 |
_bBMJ case reports _cMar 2019 |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aClopenthixol _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHallucinations _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOlanzapine _xtherapeutic use |
| 650 | 0 | 4 |
_aParanoid Disorders _xchemically induced |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGoujon, Marie Juliette | |
| 700 | 1 | _aPerez, Jesus | |
| 700 | 1 | _aMurray, Graham K | |
| 773 | 0 |
_tBMJ case reports _gvol. 12 _gno. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bcr-2018-228573 _zAvailable from publisher's website |
| 999 |
_c29541124 _d29541124 |
||